DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Rifapentine
Rifapentine
WO 2015/179249 Al 26 November 2015 (26.11.2015) P O P C T
AMEG Categorisation of Antibiotics
EMA/CVMP/158366/2019 Committee for Medicinal Products for Veterinary Use
Customs Tariff - Schedule
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Antibiotic Classes
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
Treatment Shortening for (Drug-Susceptible) Pulmonary TB: Building
Review on Antibiotic Resistance
An Activist's Guide to Rifapentine for The
Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
Common Antibiotics
Acinetobacter Baumannii Antibiotic Resistance Mechanisms
Priftin (Rifapentine) Tablets (5.3) Initial U.S
Bacterial Challenges and Evolving Antibacterial Drug Strategy B
Development of New Novel Bacterial Topoisomerase Inhibitors As Promising Antibiotics with a 5-Amino-1,3-Dioxane Linker Moiety DI
Design, Synthesis, and Evaluation of Small Molecules in the Discovery of Novel Antimicrobial Agents Kimberly D
Top View
Statistical Analysis Plan for Clinical Study Report Ac-061A301 / Ac
PRIFTIN® (Rifapentine) Tablets, for Oral Use ——————————————— CONTRAINDICATIONS ——————————————— Known Hypersensitivity to Any Rifamycin
Customs Tariff - Schedule
Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI)
Rifamycin O, an Alternative Anti-Mycobacterium Abscessus Agent
Latent Tuberculosis Infection Treatment Regimens
TRS958.Indd I 12.04.10 16:01 WHO Library Cataloguing-In-Publication Data
12-Dose Regimen for Latent TB Infection
N-Nitrosamines and Tuberculosis Medicines Rifampicin and Rifapentine
Quality of Tuberculosis Care Click
E.Johnson Supplementary
Handbook of Anti-Tuberculosis Agents
Antituberculotics and Antileprotics ●Tuberulosis (Consumption; TBC) – WHO Report: 2.109 Infected in 2009 ●Leprosy (Hansen Disese, Hanseniasis) – Approx
Drug-Induced Hyperpigmentation: Review and Case Series
Rifapentine Is Not More Active Than Rifampin Against Chronic Tuberculosis in Guinea Pigs
Pharmaceutical Composition and Kit for Treating Bacterial Infections
Treating Latent TB Infection – an Update
Anti-Leprosy Drugs: Modes of Action and Mechanisms of Resistance in Mycobacterium Leprae
Guidelines for ATC Classification and DDD Assignment 2021
Critically Important Antimicrobials for Human Medicine, 6Th Revision
Wo 2008/021089 A2
Scientific Blueprint for TB Drug Development
Critically Important Antimicrobials for Human Medicine 6Th
WHO List of Critically Important Anti-‐Microbials, 2011 Rev 3
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
Use of Rifapentine and Isoniazid Combination Therapy for the Treatment of Latent Tuberculosis Infection in Ontario
Rifampin and Rifabutin Drug Interactions an Update
Critically Important Antimicrobials for Human Medicine
3Hp Drug-Drug Interactions, Including Art
Nitrosamine Impurities Detected in Samples of Rifampin and Rifapentine
ARPEC Protocol for Drug Utilization Study
Learningpharmacology 2018.Pdf
Antibiotic Use and Resistance in Food Animals Current Policy and Recommendations © Center for Disease Dynamics, Economics & Policy, 2016
Priftin® (Rifapentine) 150 Mg Tablets
Managing and Monitoring Side Effects and Toxicities of Anti-TB Therapy
Rifalazil Retains Activity Against Rifampin-Resistant Mutants of Chlamydia Pneumoniae David M